Future Physicians Develop Conflict Of Interest Curriculum For Nation's Academic Medical Centers
Main Category: Pharmacy / PharmacistAlso Included In: Primary Care / General Practice
Article Date: 17 Nov 2009 - 2:00 PDT
The relationship between physicians and the pharmaceutical and device industries has been under recent scrutiny and several groups, including the American Medical Student Association (AMSA), have examined how medical education should prepare future physicians for the practical and ethical challenges that accompany these interactions. Today, in conjunction with the commencement of National PharmFree Week, AMSA is releasing its evidence and recommendations for a model "PharmFree" curriculum.
In the past two years, both the Association of American Medical Colleges and the Institute of Medicine have released reports detailing concerns about the relationship between industry and physicians. Both organizations recommended that academic medical centers and teaching hospitals should educate students, residents and faculty on conflicts of interest within medicine.
According to AMSA's recommendations, industry has influenced the practice of medicine through traditional advertising, manipulation of the evidence base for pharmaceuticals and devices, and by more subtle means of promotion such as showering gifts, money, and lucrative contracts on physicians, who have frequently come to accept these benefits as a well-deserved right. These practices have influenced patient care, from the drugs that physicians prescribe to the clinical research that provides the evidence base for prescription decisions.
Since its inception in 2002, AMSA's PharmFree Campaign has sought to promote evidence-based prescribing, pharmaceutical innovation and access to medicines, specifically through the implementation of conflict of interest policies at academic medical centers. Today's recommendations seek to provide medical students with the knowledge and analytical skills necessary to:
1) Understand the nature of conflicts-of-interest and how they pertain to the practice of medicine
2) Recognize how industry interaction can impact clinical care and develop strategies to mitigate the negative influences
3) Properly manage industry relations to maximize benefit to patients and public health
"The physician-industry relationship is complex and industry affects the medical practice in many direct and indirect ways," says Dr. Lauren Hughes, MPH, AMSA national president. "Medical students need formal training on the various interactions that they will inevitably have with industry as physicians. AMSA is proud to have developed a comprehensive, balanced curriculum for academic medical centers to adopt."
"The recommendations call for medical schools to implement curricula that prepare students to interact with industry in a way that protects individual patients, promotes public health and preserves the public trust in medicine," comments Chris Manz, a Duke University medical student and lead researcher for the PharmFree curriculum.
Beginning today, medical students across the country will observe National PharmFree Week, holding events aimed to promote evidence-based prescribing, pharmaceutical innovation and access to medicines. For the full Model PharmFree Curriculum and more information on the PharmFree Campaign visit www.pharmfree.org.
Source
American Medical Student Association
Visit our pharmacy / pharmacist section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/171126.php>
APA
http://www.medicalnewstoday.com/releases/171126.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Blistering One-sided Idiots
posted by Al Winston on 27 Nov 2009 at 10:24 amNo doubt AMSA feels it's newsworthy to 'go after' industry, especially given how popular it is to do so in the lay press. As I look at the foolish institutions that ban industry access to physicians due to 'undue influence' exerted on their prescribing patterns, I wonder how the public perceives such an action: "Our physicians are too stupid to look at the literature and know what's best for you." The first response of any academic center should not be, "Let's ban information flow". That instead is the action of a fascist regime.
It seems AMSA supports such an action. However, I notice AMSA has no problem with third party payers and HMOs dictating medical care. When the insurer insist on cheaper unproven generics being used instead of something the physician feels is indicated (e.g. amitriptyline for fibromyalgia instead of the only 3 other FDA approved and more expensive drugs), AMSA doesn't seem to question this. How odd, and how one-sided. Especially since the cost savings goes right into the multimillion dollar bonus of the HMO CEO.
Nice work, AMSA. Which HMO is funding your site?
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



